Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

NCT03048097 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Sarcoidosis

Interventions

DRUG: Fluorodeoxyglucose
DRUG: Rubidium
DIAGNOSTIC_TEST: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging

Sponsor

Yale University